Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
Introduction Janus kinase2 (JAK2) V617F mutation in myeloid cells has been reported from the majority of patients with Polycythemia vera (PV). Materials & Methods A cross sectional study was conducted to review clinical records of 93 cases of erythrocytosis who were evaluated for JAK2V617F...
Main Authors: | Deepti Mutreja, Sudha Sazawal, Sunita Chhikara, Manoranjan Mahapatra, Pravas Mishra, Tulika Seth, Renu Saxena |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://mjhid.org/index.php/mjhid/article/view/1784 |
Similar Items
-
Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India
by: Sudha Sazawal, et al.
Published: (2019-01-01) -
Serum erythropoietin in the evaluation of erythrocytosis: How much does it contribute to the diagnosis of polycythemia vera?
by: Ruchi Gupta, et al.
Published: (2023-01-01) -
Absence of JAK2 V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis
by: Stephen E. Langabeer
Published: (2022-12-01) -
Determining level of endogenous serum erythropoietin for differential diagnosis of polycythemia vera and symptomatic polycythemia
by: Kostyukevych O.M.
Published: (2013-06-01) -
Diagnosis of exon 12‐positive polycythemia vera rescued by NGS
by: Antoine Geay, et al.
Published: (2020-05-01)